Literature DB >> 15670722

Detection of mutations in the glycine decarboxylase gene in patients with nonketotic hyperglycinaemia.

Loryn Sellner1, Edward Edkins, Lawrence Greed, Barry Lewis.   

Abstract

Nonketotic hyperglycinaemia (NKH) is an autosomal recessive disorder of glycine metabolism caused by a deficiency in the mitochondrial glycine cleavage enzyme. The majority of cases are caused by mutations in the P-protein, one of the four components of the glycine cleavage enzyme, also known as glycine decarboxylase (GLDC). Previous studies searching for causative mutations in NKH patients have only looked for a limited number of specific mutations or only screened part of the gene, and in many cases either no mutation or only one mutation was found, which is of limited use for prenatal diagnosis. In this study, we describe the screening of the entire GLDC gene in 3 NKH families by D-HPLC analysis of all 25 exons, identifying two point mutations and two large deletions (exon 8 and exons 2-15) using a combination of D-HPLC analysis, long range PCR, Southern blot and sequencing. For complete prenatal testing both mutations need to be identified, and we suggest that screening of the entire gene as well as deletional analysis should be considered in those subjects where only one mutation has been identified.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15670722     DOI: 10.1016/j.ymgme.2004.10.001

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  4 in total

1.  Genetic heterogeneity of the GLDC gene in 28 unrelated patients with glycine encephalopathy.

Authors:  C Conter; M O Rolland; D Cheillan; V Bonnet; I Maire; R Froissart
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

2.  Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics.

Authors:  Y Ji; S Hebbring; H Zhu; G D Jenkins; J Biernacka; K Snyder; M Drews; O Fiehn; Z Zeng; D Schaid; D A Mrazek; R Kaddurah-Daouk; R M Weinshilboum
Journal:  Clin Pharmacol Ther       Date:  2010-11-24       Impact factor: 6.875

3.  Genomic deletion within GLDC is a major cause of non-ketotic hyperglycinaemia.

Authors:  Junko Kanno; Tim Hutchin; Fumiaki Kamada; Ayumi Narisawa; Yoko Aoki; Yoichi Matsubara; Shigeo Kure
Journal:  J Med Genet       Date:  2007-03       Impact factor: 6.318

4.  Binding specificity of Toll-like receptor cytoplasmic domains.

Authors:  Victoria Brown; Rachel A Brown; Adrian Ozinsky; Jay R Hesselberth; Stanley Fields
Journal:  Eur J Immunol       Date:  2006-03       Impact factor: 5.532

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.